The statement, issued February 6, 2026, by FDA Commissioner Marty Makary , emphasizes that FDA cannot verify the quality, safety, or effectiveness of these products
As of 2024, clinical trials have not shown a signal for increased thyroid cancer risk with Zepbound, but ongoing surveillance continues
Available in multiple dosage options based on your individual needs Why Choose Our Medical weight loss management in Arlington, TX
The most serious side effects of GLP-1 receptor agonists include gallbladder problems, pancreatitis, acute kidney damage, gastroparesis, bowel obstruction, and intestinal paralysis
These products mainly include topical analgesics, hand sanitizers, and sunscreens
Most people find these effects minor and temporary, especially when starting at the lowest dose